ABG Lab Mesosculpt C71

MesoSculpt C71 – a preparation developed by the American company ABG LAB LLC and manufactured in South Korea. It is designed for remodeling the subcutaneous fat mass of the face and neck area.

Composition

The composition of MesoSculpt C71® not only allows for the reduction of fat volume but also improves skin quality, enhancing the appearance and condition of the face and neck.

The core active components of MesoSculpt are LipoBlock XP2 and Hexapeptide-17.

LipoBlock XP2 is a patented element of the preparation, whose action is aimed at stimulating atraumatic lipolysis, reducing fat accumulation by adipocyte cells, and normalizing carbohydrate metabolism. Hexapeptide-17 has a lymphatic drainage effect, improves blood circulation, reduces puffiness, and enhances metabolism in the injection area.

In addition, the preparation contains amino acids, retinol, vitamins, and trace elements.

The mechanism of action of the preparation is based on altering the properties of fat cells; it changes the structure of adipocytes (fat cells), causing them to lose the ability to increase and store fat. Thanks to this cellular transformation, excess volume and swelling disappear, the skin tightens, and becomes firmer and more even.

MesoSculpt C71® is used to eliminate a double chin, malar bags, reduce cheeks, and excess volume in the nasolabial fold area. The preparation targets fat deposits in the middle and lower third of the face, correcting the contour and oval of the face.

The procedure is contraindicated during acute inflammatory processes, in autoimmune diseases, under the age of eighteen, during pregnancy, and lactation.